Herzog elected president of GOG Foundation board

Thomas Herzog, MD, Class of 1986, deputy director of the UC Cancer Center and professor in the Department of Obstetrics and Gynecology, has been elected president of the GOG Foundation, Inc. (GOG-F) Board of Directors. He will serve as the president-elect for one-year before becoming president in July 2023.

Founded in 1970 as the Gynecologic Oncology Group, the GOG-F is a not-for-profit organization that conducts clinical and translational research on the prevention and treatment of gynecologic malignancies. The GOG-F includes the GOG Foundation, corporate membership in NRG Oncology and the GOG-P program. In addition to the NRG responsibilities, Herzog also will oversee the GOG Partners program. The GOG-F consists of gynecologic oncologists, medical oncologists, pathologists, radiation oncologists, oncology nurses, biostatisticians, basic scientists, quality of life experts, data managers and administrative personnel.

Herzog, who also is the Paul and Carolyn Flory Professor of Gynecologic Oncology, has been a member of the GOG-F Board of Directors, has served as treasurer for the past eight years and is currently an associate director of the GOG Partners program, which collaborates with pharmaceutical organizations to operate clinical trials. He serves or has served on the editorial boards of Gynecologic Oncology, Obstetrics and Gynecology International, and Hematology Oncology Times, among others, and has served as editor-in-chief of Women’s Oncology Review and Gynecologic Oncology Research to Practice. Herzog also has served on the boards or leadership councils of the Society of Gynecologic Oncology, Foundation for Women’s Cancer, American College of Surgeons, American Board of Obstetrics and Gynecology-Gynecologic Oncology Division and the International Gynecologic Cancer Society.